Skip to content

Continuous peritoneal infusion of ropivacaine following laparoscopy for postoperative analgesia in children: a randomized, double-blind, placebo-controlled study. - Peritoneal infusion of ropivacaine following laparoscopy in children.

Continuous peritoneal infusion of ropivacaine following laparoscopy for postoperative analgesia in children: a randomized, double-blind, placebo-controlled study. - Peritoneal infusion of ropivacaine following laparoscopy in children.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-002724-29-IT
Enrollment
Unknown
Registered
2008-06-12
Start date
2011-10-26
Completion date
Unknown
Last updated
2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children aged over 1 year, undergoing elective abdominal laparoscopic surgery. MedDRA version: 9.1 Level: LLT Classification code 10023693 Term: Laparoscopy

Interventions

Product Name: Ropivacaine Pharmaceutical Form: Solution for injection INN or Proposed INN: Ropivacaine Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number:

Sponsors

ISTITUTO PER L'INFANZIA BURLO GAROFOLO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Enlisting of 60 children aged over 1 year, undergoing elective abdominal laparoscopic surgery, is planned. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Excluding parameters will be: conversion from laparoscopy to open approach, diagnostic laparoscopy.

Design outcomes

Primary

MeasureTime frame
Main Objective: Safety and efficacy of continuous peritoneal infusion of local anesthetics (ropivacaine)in children. To date it is unknown whether the technique is reliable, safe and which is the optimal dosage of the local anesthetic administered. The choice of extended use of continuous peritoneal infusion of ropivacaine also in the child, where postoperative pain relief is necessary, avoiding opioid side effects, is wished.;Secondary Objective: Evaluate postoperative analgesia, showing the efficacy and the safety of continuous peritoneal infusion of ropivacaine, in children after laparoscopic abdominal surgery. This study will evaluate the efficacy and the safety of the dosage of ropivacaine administered, the incidence of postoperative complications (respiratory depression, PONV, infections), the time to bowel transit recovery, the blood absorption of intraperitoneally instillated ropivacaine and the signs or symptoms of local anesthetic toxicity.;Primary end point(s): Aim of this study is to evaluate postoperative pain in children during the 24 hours following surgery. Postoperative evaluation will be done both by medical and nursing staff using CHEOPS scale after 1, 2, 3, 4, 8, 16 and 24 hours after surgery. Pain assessment is different at different pediatric ages. Opioids dosage administered will be evaluated too.

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026